Cash Flow Basilea Pharmaceutica AG Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
45.00
60.00
10.00
12.00
-6.00
-14.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
8.00
6.00
-4.00
-11.00
-31.00
-30.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
62.00
74.00
14.00
7.00
-32.00
-54.00
Cash Flow from Investing Activities
-2.00
-1.00
-1.00
91.00
3.00
-34.00
Cash Flow from Financing Activities
-21.00
-13.00
-57.00
-45.00
16.00
45.00
Net Cash Inflow / Outflow
37.00
60.00
-44.00
53.00
-11.00
-44.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in CHF Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Basilea Pharmaceutica AG
Figures in Million
consolidated Cash Flow Results
Change(CHF)
Change(%)
Profit Before Tax
45.875
-0.860412445438017
45.00
5431.75%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
8.765
-4.18959001210015
12.00
309.21%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
62.09
-10.8170152862747
72.00
674.00%
Cash Flow from Investing Activities
-2.862
46.4200949729942
-48.00
-106.17%
Cash Flow from Financing Activities
-21.425
-22.919962898411
1.00
6.52%
Net Cash Inflow / Outflow
37.777
10.843258803129
27.00
248.39%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-0.026
-1.83985798517955
1.00
98.59%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
YoY Growth in year ended Dec 2025 is -16.50% vs 422.03% in Dec 2024
Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
62.09
74.36
-16.50%
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
